SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 17, 2013

 

BOND LABORATORIES, INC.

(Exact name of Registrant as specified in its Charter)

 

 




Nevada

000-52369

20-3464383

 

(State or other jurisdiction

of incorporation)

(Commission File No.)

(IRS Employer

Identification No.)

 

 



4509 143rd Street, Suite 1, Omaha, Nebraska 68137

 

(Address of principal executive offices)

 


 

(402) 333-5260

 

(Registrants Telephone Number)

 


 

Not Applicable

 

(Former name or address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 





Item 5.07  Submission of Matters to a Vote of Security Holders.


On July 17, 2013, Bond Laboratories, Inc. (the Company) held its annual meeting of stockholders (the Annual Meeting). The matters voted upon at the Annual Meeting and the results of the voting are set forth below.


Proposal No. 1- Election of Directors




For


Withheld


John Wilson


44,898,900


246,180


Michael Abrams


44,647,900


497,180


Lewis Jaffe


39,326,653


5,818,427



The Companys Directors are elected by a plurality of the votes cast. Accordingly, each of the nominees named above were elected to serve on the Board of Directors until the 2014 annual meeting of stockholders, or until their successors are elected and qualified.


Proposal No. 2- Reverse Stock Split


For


Against


Abstain


50,744,923


5,225,911


6,170,904



The vote required to approve this proposal was the affirmative vote of a majority of the votes cast on the proposal. Accordingly, the stockholder resolution authorizing the Companys Board of Directors to amend its Articles of Incorporation in order to implement a reverse stock split of the Companys common stock at a ratio of not less than 1-for-10, but not greater than 1-for-40, at any time prior to December 31, 2014, with the exact ratio to be determined by the Board of Directors, was approved.


Proposal No. 3- Change of Company Name


For


Against


Abstain


55,453,354


336,101


6,352,284



The vote required to approve this proposal was the affirmative vote of a majority of the votes cast on the proposal. Accordingly, the amendment to the Companys Articles of Incorporation to change the name of the Company to FitLife Brands, Inc. was approved.



Proposal No. 4- Advisory Vote to Approve Executive Compensation (Say-On-Pay Proposal)


For


Against


Abstain


36,966,010


8,006,817


172,253



The vote required to approve this proposal was the affirmative vote of a majority of the votes cast on the proposal. Accordingly, stockholders voted, on an advisory basis, in favor of the compensation paid to the Companys named executive officers, as disclosed in the Executive Compensation section of the Companys definitive proxy statement, dated June 14, 2013.


Proposal No. 5- Advisory Vote to Approve the Frequency of Advisory Votes on Executive Compensation


One Year


Two Years


Three Years


Abstain


16,896,991


594,425


27,484,484


169,180



Based upon the results of voting on this proposal, and consistent with the Boards previous recommendation, the Board has determined that the Companys stockholders will vote on a Say-On-Pay Proposal every three years, until the next required vote on the frequency of such Say-On-Pay Proposals at the Companys 2019 annual meeting of stockholders.


Proposal No. 6- Ratification of Appointment of Auditors

 

For


Against


Abstain

61,078,350


424,496


638,894


The vote required to approve this proposal was the affirmative vote of a majority of the votes cast on the proposal. Accordingly, stockholders ratified the appointment of Tarvaran Askelson & Company, LLP as the Companys independent auditors for the fiscal year ending December 31, 2013


For more information about the foregoing proposals, please review the Companys definitive proxy statement, filed with the Securities and Exchange Commission on June 12, 2013.










SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 






 

 

BOND LABORATORIES, INC.





Date: July 19, 2013

 

By:

 /s/ Michael Abrams

 

 

 

Michael Abrams

 

 

 

Chief Financial Officer